NUDCD1 抗体 (AA 431-530) (AbBy Fluor® 647)
Quick Overview for NUDCD1 抗体 (AA 431-530) (AbBy Fluor® 647) (ABIN6980207)
抗原
适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 431-530
-
交叉反应
- 小鼠
-
预测反应
- Human,Rat,Dog,Cow,Sheep,Horse,Rabbit,Zebrafish
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human NUDCD1
-
亚型
- IgG
-
-
anti-NudC Domain Containing 1 (NUDCD1) (AA 332-583) antibody
NUDCD1 适用: 人 WB, IHC (p), IHC 宿主: 兔 Polyclonal unconjugated
anti-NudC Domain Containing 1 (NUDCD1) (N-Term) antibodyNUDCD1 适用: 人, 小鼠, 大鼠, 犬, 豚鼠, 兔, 马, 猴, Bat WB 宿主: 兔 Polyclonal unconjugated
anti-NudC Domain Containing 1 (NUDCD1) (AA 304-583) antibodyNUDCD1 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-NudC Domain Containing 1 (NUDCD1) (N-Term) antibodyNUDCD1 适用: 人, 小鼠, 大鼠 WB 宿主: 兔 Polyclonal unconjugated
anti-NudC Domain Containing 1 (NUDCD1) (N-Term) antibodyNUDCD1 适用: 人, 小鼠, 大鼠, 犬, 豚鼠, 兔, Cow, 马 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- NUDCD1 (NudC Domain Containing 1 (NUDCD1))
-
别名
- NUDCD1
-
背景
-
Synonyms: 4921532K09Rik, AA407246, AW260430, AW556235, Chronic myelogenous leukemia tumor antigen 66, CML66, CML66 L, FLJ14991, NudC domain containing 1, NudC domain-containing protein 1, NUDC1_HUMAN, nudcd1, OVA66, RGD1310624, Tumor antigen CML66.
Background: The NUDCD1 gene encodes the 583 amino acid CML66 protein which demonstrates expression in a variety of solid tumor cell lines and leukemias. Expression of CML66 in normal tissues is restricted to testis and heart. The CML66 antibody is found in sera of 18-38 % of patients with lung cancer, melanoma or prostate cancer. These findings indicate that CML66 may be immunogenic in a wide variety of malignancies and may be a target for antigen-specific immunotherapy. A short isoform of CML66, designated CML66-S, is a product of alternative splicing. CML66-S has the same C-terminus as full-lenghth CML66 (also designated CML66-L), but has a unique N-terminus. CML66-S shows predominant expression in testis, and is also expressed in very low levels in tumor cells, while CML66 is expressed in tumor cells and testis.
-
基因ID
- 84955
-
UniProt
- Q96RS6
抗原
-
